Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.
about
Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsisHematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury.
P2860
Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Oligonucleotide IMT504 induces ...... ic lymphocytic leukemia cells.
@en
Oligonucleotide IMT504 induces ...... ic lymphocytic leukemia cells.
@nl
type
label
Oligonucleotide IMT504 induces ...... ic lymphocytic leukemia cells.
@en
Oligonucleotide IMT504 induces ...... ic lymphocytic leukemia cells.
@nl
prefLabel
Oligonucleotide IMT504 induces ...... ic lymphocytic leukemia cells.
@en
Oligonucleotide IMT504 induces ...... ic lymphocytic leukemia cells.
@nl
P2093
P1476
Oligonucleotide IMT504 induces ...... ic lymphocytic leukemia cells.
@en
P2093
Alejandro Montaner
Dardo Riveros
Fernanda Elias
Jorge Solimano
Jorge Zorzopulos
Jose Fernandez
Juan Dupont
Juan M Rodriguez
P577
2006-01-01T00:00:00Z